Share on Pinterest Could a new oral option help to meet the growing demand for GLP-1 medications? Image Credit: Medical News Today/Photo by Eli Lilly The Food and Drug Administration (FDA) has ...

23andMe Research Institute, a nonprofit medical research organization, announced the publication of a study that identifies genetic predictors for GLP-1 weight loss efficacy and side effects. GLP-1 ...

The Food and Drug Administration on Wednesday approved a new weight loss pill from drugmaker Eli Lilly. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive ...

The brief reign of Novo Nordisk’s Wegovy pill as the lone oral GLP-1 approved for obesity has ended as Eli Lilly’s orforglipron cruised past an FDA green light Wednesday. Now christened Foundayo, the ...

A couple of decades ago, GLP-1 drugs were a specialised treatment for type-2 diabetes but, fast-forward to today, and they have become much more widespread, being sold to help people with obesity and ...

While Lilly’s position in the obesity market and wider GLP-1 space has remained largely unshakeable in recent months, a crack in the company’s armor may be forming, according to at least one analyst.

Researchers also noted a reduced risk of self-harm among people taking GLP-1 medications Angelique Brenes is a writer-reporter at PEOPLE. She joined PEOPLE in 2026. Her work has previously appeared on ...

Kendra Wilkinson is ready to start a new wellness journey — with a little help. According to Wilkinson — who has said goodbye to the bright lights of reality TV to focus on her real estate career — ...

Share on Pinterest New research suggests that GLP-1s could offer dual benefits for treating both metabolic and mental health issues. Catherine Falls Commercial/Getty Images A new study found that ...

Share on Pinterest Almost half of the people who stop GLP-1 drugs may be able to prevent weight regain, a new study suggests. Image credit: FreshSplash/Getty Images A real-world study followed ...

Investigators tried to draw direct comparisons between GLP-1 receptor agonists versus bariatric surgery in patients undergoing Afib ablation using a retrospective cohort study. Findings gave GLP-1 ...

Although one GLP-1 study made national headlines about the drug class’ potential use in addiction treatment, other research indicates GLP-1s could increase the risk of bone injuries and are less ...